Synlogic Files 2024 Annual Report Amendment
Ticker: SYBX · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1527599
| Field | Detail |
|---|---|
| Company | Synlogic, Inc. (SYBX) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Synlogic filed its amended 2024 10-K on 4/30/25. Check for updates.
AI Summary
Synlogic, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 30, 2025, provides updated information for the company, which is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. Synlogic, formerly Mirna Therapeutics, Inc., is headquartered in Winchester, MA.
Why It Matters
This amendment provides updated financial and operational information for Synlogic, Inc., which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Synlogic is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 001-37566 — SEC File Number (Identifies the company's filings with the SEC.)
- 26-1824804 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- SYNLOGIC, INC. (company) — Registrant
- 2024-12-31 (date) — Fiscal year end
- 2025-04-30 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- PHARMACEUTICAL PREPARATIONS (industry) — Standard Industrial Classification
- Mirna Therapeutics, Inc. (company) — Former company name
- PO Box 30 Winchester , MA 01890 (address) — Principal business address
FAQ
What specific changes or updates are detailed in this 10-K/A amendment?
The filing is an amendment (No. 1) to the annual report for the fiscal year ended December 31, 2024, indicating that the original filing required corrections or additions.
When was the original 10-K filed, and what is the purpose of this amendment?
The original 10-K was likely filed prior to April 30, 2025, and this amendment (10-K/A) serves to correct or supplement information previously reported.
What is Synlogic, Inc.'s primary business sector?
Synlogic, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
What was Synlogic, Inc. formerly known as?
Synlogic, Inc. was formerly known as Mirna Therapeutics, Inc., with a name change occurring on August 9, 2011.
Where is Synlogic, Inc. headquartered?
Synlogic, Inc. is headquartered in Winchester, MA, with its principal business address listed as PO Box 30, Winchester, MA 01890.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding SYNLOGIC, INC. (SYBX).